Reliance gets nod to start Covid-19 vaccine trials

Reliance Life Sciences (RLS), part of India's largest conglomerate, is expected to start phase I clinical studies of its indigenous Covid-19 vaccine soon. The Subject Expert Committee (SEC), which advises the drug regulator on vaccines and new drugs, reviewed the company’s application and is learnt to have recommended it for approval on Thursday.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3kvvGN6
https://ift.tt/2WrB1N9